Back
Stoke Therapeutics Stock Price Chart

He's already IPO'd once - this time's different
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
23
STOK
Stoke Therapeutics
Last Price:
$7.58
Seasonality Move:
-2.4%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and STOK is experiencing buying pressure, which is a positive indicator for future bullish movement.
Stoke Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.46 | Buy |
20-day SMA: | 7.14 | Buy |
50-day SMA: | 8.57 | Sell |
200-day SMA: | 11.77 | Sell |
8-day EMA: | 6.78 | Buy |
20-day EMA: | 7.1 | Buy |
50-day EMA: | 8.21 | Sell |
200-day EMA: | 10.39 | Sell |
Stoke Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.51 | Sell |
Relative Strength Index (14 RSI): | 52.44 | Buy |
Chaikin Money Flow: | 552322 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.44 - 8.38) | Buy |
Bollinger Bands (100): | (7.85 - 11.95) | Sell |
Stoke Therapeutics Technical Analysis
Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Stoke Therapeutics Stock
Is Stoke Therapeutics Stock a Buy?
-
Stoke Therapeutics share price is 7.56 while STOK 8-day simple moving average is 6.46, which is a Buy signal.
-
The stock price of STOK is 7.56 while Stoke Therapeutics 20-day SMA is 7.14, which makes it a Buy.
-
Stoke Therapeutics 50-day simple moving average is 8.57 while STOK share price is 7.56, making it a Sell technically.
-
STOK stock price is 7.56 and Stoke Therapeutics 200-day simple moving average is 11.77, creating a Sell signal.
STOK Technical Analysis vs Fundamental Analysis
Sell
23
Stoke Therapeutics (STOK)
is a Sell
Is Stoke Therapeutics a Buy or a Sell?
-
Stoke Therapeutics stock is rated a SellThe current Stoke Therapeutics [STOK] share price is $7.56. The Score for STOK is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Stoke Therapeutics Stock Info
Market Cap:
408.8M
Price in USD:
7.56
Share Volume:
818.3K
Stoke Therapeutics 52-Week Range
52-Week High:
17.58
52-Week Low:
5.35
Sell
23
Stoke Therapeutics (STOK)
is a Sell
Stoke Therapeutics Share Price Forecast
-
What is the Stoke Therapeutics stock price today?The Stoke Therapeutics stock price is 7.56 USD today.
-
Will STOK stock go up or go down?Stoke Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Stoke Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Stoke Therapeutics is overvalued.
Is Stoke Therapeutics Stock a Buy?
-
Stoke Therapeutics share price is 7.56 while STOK 8-day exponential moving average is 6.78, which is a Buy signal.
-
The stock price of STOK is 7.56 while Stoke Therapeutics 20-day EMA is 7.10, which makes it a Buy.
-
Stoke Therapeutics 50-day exponential moving average is 8.21 while STOK share price is 7.56, making it a Sell technically.
-
STOK stock price is 7.56 and Stoke Therapeutics 200-day simple moving average is 10.39, creating a Sell signal.
Fundamental Analysis of Stoke Therapeutics
Is Stoke Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and a decrease next year of $0.66 per share.
Technical Analysis of Stoke Therapeutics
Should I short Stoke Therapeutics stock?
-
STOK Moving Average Covergence Divergence (MACD) indicator is -0.51, suggesting Stoke Therapeutics is a Sell
-
Stoke Therapeutics Relative Strength Index (RSI) is 52.44, which suggest Stoke Therapeutics is overbought
-
The Bollinger Bands (25) for Stoke Therapeutics is (6.44 - 8.38), which suggest Stoke Therapeutics is a Sell
-
The Bollinger Bands (100) for Stoke Therapeutics is (7.85 - 11.95), which suggest Stoke Therapeutics is a Sell
* Stoke Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.